• Title/Summary/Keyword: 헤파린 도관

Search Result 6, Processing Time 0.023 seconds

The Effects of Heparin-Coated Circuit on the Total Amount of Heparin During Cardiopulmonary Bypass (심폐기 사용 중에 HCC가 총 Heparin사용량에 미치는 영향)

  • 이현우;이재웅;박철현;박국양
    • Journal of Chest Surgery
    • /
    • v.33 no.12
    • /
    • pp.954-958
    • /
    • 2000
  • 배경: 헤파린표면처리 도관(Heparin-coated circuit: HCC)이 도관과 혈액사이의 반응(Blood-marterial reaction)을 줄여주어서 보체활성화(complement activation), 백혈구활성화(leukocyte activation)와 사이토킨 분비(cytokinerelease)등을 감소시켜 준다. 그러나 HCC가 수술 후에 출혈 양을 줄여주고 헌혈 필요량을 감소시켜 준다는 임상적 효과에 대해서는 인정된 부분이 많으나 아직까지 그 기전은 대부분은 미지의 상태로 남아있는 것이 사실이다. 본 연구는 HCC를 사용한 군(Group H)과 사용하지 않은 군(Group C)간에 심폐기 사용기간(Pumptime), 활성화 응고시간(activated clotting time: ACT)과 헤파린 사용량을 비교 분석해 봄으로서 두 군간에 존재할 수 있는 헤파린 사용량을 비교 분석해 본으로서 두 군간에 존재할 수 있는 헤파린 사용량 차이에 대하여 알아보려고 하게되었다. 대상 및 방법: 본원에서 1999년 5월 1일부터 동년 12월 31일 사이에 연령이 16세 이상인 환자에서 HCC를 사용했던 16명(Group H)과 사용하지 않았던 19명(Group C)을 대상으로 하였다. 모든 환자에서 수술 전 체중, 신장, 체표면적, 심폐기 사용시간(pumptime), 수술 중 최저체온, 대동맥 차단시간(Aortic cross clamping time. ACC time), ACT, 헤파린 및 프로타민 사용 양 등을 조사하였다. 결과: 연구대상 환자의 연령, 체중, 신장, 체표면적, 대동맥차단 시간, 체온 등은 HCC를 사용한 군(H 군)과 사용하지 않은 군(C군)간에 의미 있는 차이가 없었다(p<0.05). 헤파린 공급 전, 공급 후 20분, 40분, 60분과 프로타민 공급 후 20분에 측정한 ACT는 두 군간에 의미 있는 차이가 없었다. 두 군간의 처음에 공급한 헤파린 양과 총 프로타민 사용량은 차이가 없었으나(p>0.05), 추가 공급한 헤파린 양(11$\pm$30 versus 67$\pm$49mg, p<0.05)과 총 헤파린 사용량(176$\pm$44 versus 239$\pm$70mg, p<0.05)은 H군에서 의미 있게 적게 나왔다. 두 군간에서 심폐기 사용시간에는 차이가 없었으면서 H군에서 약 38%정도의 헤파린을 적게 사용하였다. 결론: 결론적으로 HCC의 사용으로 심폐기 사용 시간과 상관없이 추가하는 헤파린 양을 줄임으로서 총 헤파린 사용량을 줄여 줄 수 있었으며 이것이 HCC의 임상적 효과를 나타나게 하는 하나의 요소로 작용할 수 있다고 생각된다.

  • PDF

Development of Korean Version of Heparin-Coated Shunt (헤파린 표면처리된 국산화 혈관우회도관의 개발)

  • Sun, Kyung;Park, Ki-Dong;Baik, Kwang-Je;Lee, Hye-Won;Choi, Jong-Won;Kim, Seung-Chol;Kim, Taik-Jin;Lee, Seung-Yeol;Kim, Kwang-Taek;Kim, Hyoung-Mook;Lee, In-Sung
    • Journal of Chest Surgery
    • /
    • v.32 no.2
    • /
    • pp.97-107
    • /
    • 1999
  • Background: This study was designed to develop a Korean version of the heparin-coated vascular bypass shunt by using a physical dispersing technique. The safety and effectiveness of the thrombo-resistant shunt were tested in experimental animals. Material and Method: A bypass shunt model was constructed on the descending thoracic aorta of 21 adult mongrel dogs(17.5-25 kg). The animals were divided into groups of no-treatment(CONTROL group; n=3), no-treatment with systemic heparinization(HEPARIN group; n=6), Gott heparin shunt (GOTT group; n=6), or Korean heparin shunt(KIST group; n=6). Parameters observed were complete blood cell counts, coagulation profiles, kidney and liver function(BUN/Cr and AST/ ALT), and surface scanning electron microscope(SSEM) findings. Blood was sampled from the aortic blood distal to the shunt and was compared before the bypass and at 2 hours after the bypass. Result: There were no differences between the groups before the bypass. At bypass 2 hours, platelet level increased in the HEPARIN and GOTT groups(p<0.05), but there were no differences between the groups. Changes in other blood cell counts were insignificant between the groups. Activated clotting time, activated partial thromboplastin time, and thrombin time were prolonged in the HEPARIN group(p<0.05) and differences between the groups were significant(p<0.005). Prothrombin time increased in the GOTT group(p<0.05) without having any differences between the groups. Changes in fibrinogen level were insignificant between the groups. Antithrombin III levels were increased in the HEPARIN and KIST groups(p<0.05), and the inter-group differences were also significant(p<0.05). Protein C level decreased in the HEPARIN group(p<0.05) without having any differences between the groups. BUN levels increased in all groups, especially in the HEPARIN and KIST groups(p<0.05), but there were no differences between the groups. Changes of Cr, AST, and ALT levels were insignificant between the groups. SSEM findings revealed severe aggregation of platelets and other cellular elements in the CONTROL group, and the HEPARIN group showed more adherence of the cellular elements than the GOTT or KIST group. Conclusion: Above results show that the heparin-coated bypass shunts(either GOTT or KIST) can suppress thrombus formation on the surface without inducing bleeding tendencies, while systemic heparinization(HEPARIN) may not be able to block activation of the coagulation system on the surface in contact with foreign materials but increases the bleeding tendencies. We also conclude that the thrombo-resistant effects of the Korean version of heparin shunt(KIST) are similar to those of the commercialized heparin shunt(GOTT).

  • PDF

Evaluation of Biocompatibility of Extracorporeal Circuit - Development of a Quantification Technique using in-vivo Injection of Tc99m Radioactive Platelets - (체외순환도관의 혈액적합성 평가 - 방사선 동위원소(Tc99m) 활성화 혈소판의 생체 내 주입을 이용한 정량분석법의 개발 -)

  • Lee, Sung-Ho;Sun, Kyung;Choi, Jai-Geol;Son, Ho-Sung;Jung, Jae-Seung;Ahn, Sang-Soo;Oh, Hye-Jung;Lee, Whan-Sung;Lee, Hye-Won;Kim, Kwang-Taik;Jeong, Yoon-Seop;Kim, Young-Ha;Kim, Hyoung-Mook
    • Journal of Chest Surgery
    • /
    • v.35 no.3
    • /
    • pp.171-176
    • /
    • 2002
  • Background: Blood-foreign interaction cause activation of coagulation and inflammatory process that may lead to multiorgan dysfunction and determine the surgical outcomes. Of the methods for assessing the biocompatibility, the platelet adhesion study is considered as the most valuable evaluation step in blood-foreign interaction. As the most studies have used in-vitro or ex-vivo conditions, we have developed a technique of quantification for platelet adhesion on the blood contact surface by using in-vivo injection of radioactive platelets. Material and Method: A coupled bypass circuit was designed to connect the proximal and descending thoracic aorta in 6 piglets(20∼25 Kg). One side of the circuit tube was consisted of a heparin coated PVC tube(10mm in ID, n=6, Experimental group), and the other, a non-heparin coated PVC tube(10mm in ID, n=6, Control group). After cannulation, the blood was circulated through the circuit for 2 hours. Platelet concentrate was prepared from homologous pig blood 24 hours before the experiment. The platelet concentrate was incubated with Tc-99m-HMPAO for 30 min and then centrifuged for 10 min. The supernatant was discarded and the radio-labeling efficacy was measured. The radio-labeled platelet concentrate was mixed with the autologous plasma to make the volume 5 ml, and the mixture was injected intravenously into the experimental animal. After 2 hour circulation, 5 pieces of the specimen(10mm in length each) were obtained from each PVC tube. The radioisotopes were counted with a gamma counter(Cobra ll, Packard, USA), and the ratio of radioisotope count was compared between the control and experimental group. Result: The radioisotope count number was 537.3221.1 Ci/min in the control group and 311.1 184.5 Ci/min in the experimental group(p=0.0104). The ratio between the groups was 1 to 0.58 (p=0.004). Conclusion: In vivo quantification using technetium-99m-HMPAO labeled platelets is simple and reproducible in evaluating platelet adhesion on a foreign surface. We suggest this technique to be a useful tool for blood compatibility test.

A case of pulmonary thromboembolism in a healthy infant (건강한 영아에서 발생한 폐혈전색전증 1례)

  • Choi, Woo-Yeon;Choi, Young-Seok;Oh, Soo-Min;Cho, Young-Kuk;Ma, Jae-Sook
    • Clinical and Experimental Pediatrics
    • /
    • v.50 no.10
    • /
    • pp.1030-1033
    • /
    • 2007
  • A pulmonary thromboembolism (PTE), which is a sudden blockage in a pulmonary artery, usually due to a blood clot, is rare in children. The clinical presentation is often subtle or masked by the underlying clinical condition and the condition must be suspected during clinical testing. Although the choice of treatment depends on the clinical presentation, anticoagulation is the mainstay of therapy for children with PTE. We report the case of a healthy 1-month-old boy who presented with hemoptysis without hemodynamic instability. He was diagnosed based on chest computed tomography with angiography and 99mTc macroaggregated albumin lung perfusion scintigraphy and treated with low-molecular-weight heparin.

The Efficacy of Endovascular Treatment for Deep Vein Thrombosis (하지 심부정맥 혈전증에서 중재적 치료의 유용성)

  • Kim, Seon-Hee;Chung, Sung-Woon;Kim, Chang-Won
    • Journal of Chest Surgery
    • /
    • v.43 no.3
    • /
    • pp.266-272
    • /
    • 2010
  • Background: Deep vein thrombosis (DVT) is a serious disease that causes life-threatening pulmonary embolism and chronic venous insufficiency. Anticoagulation is the standard therapy for DVT. However, the results of standard anticoagulation for treating DVT have been disappointing, so endovascular treatment is commonly performed nowadays. The aim of this study was to evaluate the efficacy of an endovascular procedure for treating patients with DVT. Material and Method: We retrospectively evaluated the clinical data of 29 DVT patients who underwent an endovascular procedure between December 2006 and July 2008. We compared the results of the 29 patients with the results of another 45 patients who were treated with only aspirin and heparin. Result: The patient’s mean age was 55.4 years in the intervention group and 53.7 years in the control group. DVT occurred more frequently in the females. Catheter-directed thrombolysis was performed in 22 patients (75.8%). Aspiration thrombectomy was performed in 18 patients (62%) and a endovascular stent was placed in 25 patients (86.2%). Fifteen patients (51.7%) underwent percutaneous insertion of a retrievable IVC filter for the prevention of pulmonary embolism. In the control group, thirty nine patients (86.7%) were treated with low-molecular heparin, and seven patients (15.6%) who were contraindicated for warfarin were treated with aspirin. No bleeding complications occurred during thrombolysis or anticoagulation. We analyzed the statistical data according to recurrence of DVT and the incidence of post-thrombotic syndrome (PTS) during the follow-up period. The intervention group had a significantly lower incidence of PTS (p-value=0.008), but they had the same result as the control group for the recurrence of DVT. In addition, death from the DVT did not occur in the intervention group. Thus, we obtained better clinical outcomes in the intervention group as compared to those in the anticoagulation only group. Conclusion: Endovascular procedures are effective alternative modalities, as compared to systemic anticoagulation, for the treatment of DVT. But more studies are needed to determine the specific indications and to validate the long-term efficacy of endovascular procedures for the treatment of DVT.

Quality Characteristics of Bread with Dried Persimmons Hot-Water Extracts (곶감 열수추출물을 첨가한 식빵의 품질특성)

  • 문혜경;한진희;김준한;김귀영;강우원;김종국
    • Journal of the Korean Society of Food Science and Nutrition
    • /
    • v.33 no.4
    • /
    • pp.723-729
    • /
    • 2004
  • To develop foods using dried persimmon, hot-water extracts of dried persimmons were added into strong wheat flour in the ratio of 10, 20, 30, and 40% and the quality characteristics of baked products were investigated. The proximate compositions of dried persimmons hot-water extracts were 70.37% of moisture, 1.72% of crude protein, 0.18% of crude lipids, 1.99% of crude ash and 4.37% of crude fiber, respectively. With increasing the addition of dried persimmons hot-water extracts, moisture content of the added breads was increased to 47.20% from 41.12% of non-added bread and water activity to 0.576 from 0.495. Water binding capacity of the added dried persimmons hot-water extracts rasied weight of the bread but decreased specific volume. In the hunter's color values the more dried persimmons hot-water extracts was added, the lower L vaules we, and the higher a and b values we. In the texture property, the addition of dried persimmons hot-water extracts increased hardness, gumminess and chewiness, while decreased adhesiveness and fracturability. Judging from texture, taste and overall acceptability of the product, recommended substitution level for hot-water extracts of dried persimmons in bread was 30% or less.